Official UK procurement notice
Seasonal Influenza Vaccines · UK public procurement notice
Authority: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) (NHS & healthcare)
What is being bought3 lots · detail below
Published requirement descriptionSupply of influenza vaccines for use in the NHS Scotland 2025/26 seasonal flu programme.
CPV: Influenza vaccines
Lots and requirements (3)Procurement structure
3 lots · all with a published value (£14,225,000 together) · same evaluation weights on every lotLot #1Influenza Vaccine for adults aged 65 years and above as recommended by JCVI for 2025/26AwardedPublished value£9,000,000
Supply of adjuvanted trivalent influenza vaccines to NHS Scotland for use in the 2024/25 NHS Scotland Seasonal Flu Programme. The Authority awards this Lot as a Commitment Contract to a single supplier.
Lot #2Influenza Vaccines for persons aged 18 to 64 years, as recommended by JCVI for 2025/26AwardedPublished value£5,000,000
Supply of cell-based trivalent influenza vaccines to NHS Scotland for use in the 2024/25 NHS Scotland Seasonal Flu Programme.
Lot #3Cell-based Influenza Vaccine for children aged 6 months to 17 years, as recommended by JCVI for 2025/26Published value£225,000
Supply of cell-culture influenza vaccines as recommended by JCVI for children aged 6 months to 17 years to NHS Scotland for use in the 2025/26 NHS Scotland Seasonal Flu Programme. The Authority intends to award this Lot as a Commitment Contract to a single supplier.
Full details of the Goods and volumes can be found within the ITT documents
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Published sub-criteria (2)
- Delivery Schedule: 10%
- price: 90%
Published award criteria (2)
- Delivery Schedule: 10
- Price: 90
- Technical & professional ability
(a) Potential Contractors must be able to demonstrate the existence of a valid and current UK Marketing Authorisation (PL, PLGB, or PLPI number) that has been approved by the MHRA for all tendered Goods at the date of submission of the tender / Contract start date.
(b)Potential Contractors and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent.
Minimum: (a) Confirmation of existence of a valid and current UK Marketing Authorisation (PL, PLGB, PLPI number) that has been approved by the MHRA for all tendered Goods at the date of submission of the tender should be included in the Qualification Envelope of the ITT under the Technica…
- Price carries 90 of 100 points: a 10% discount moves about 9 points. This one is won on the number: sharpen the price before polishing the prose.
Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- No (one-off requirement)
- First published
- 1 Nov 2024, 13:29 GMT
- Last source update
- 13 Jan 2025, 10:43 GMT
- Award evaluation window
- 18 Nov 2024 – …
- Authority reference
NP93825- FTS notice number
2025/S 000-000988- Accelerated
Vaccine manufacturers have advised that Contracts for supply of flu vaccines for the 2025/26 flu programme must be awarded no later than
December to secure the required volumes/capacity with their manufacturing sites.
- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-04b34bFind a Tender
- Electronic trading
- e-invoicing allowed · electronic ordering · electronic payment
- Review procedure
The bringing of court proceedings against the Authority after the contract has been entered into will not affect the contract unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the contract has been entered into are limited to the award of damages.
Publisher note: The estimated values referred to in Section II.1.7 [and within all Lots] cover the twelve (12) month contract duration. (SC Ref:786125)
How it was run
Official noticeTender documents are also served through a separate tool: https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html ↗
- Submission deadline
- 18 Nov 2024, 14:00 GMT
- Submission channel
- {"electronicSubmission"}
- Accepted languages
- en
- Bid validity
- 90 days from the deadline
- Bids opened
- 18 Nov 2024, 14:00 GMT
Timeline
18 Nov 2024 → 13 Jan 2025 · 3 dates- Submission deadline18 Nov 2024, 14:00 GMT
- Bids opened18 Nov 2024, 14:00 GMT
- Notice published13 Jan 2025, 10:43 GMT
Notice history
1 event · 2 releases on Find a Tender- Status changed to complete13 Jan 2025, 10:43 GMT
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Lot 1 · Influenza Vaccine for adults aged 65 years and above as recommended by JCVI for 2025/261 award | |||
| Seqirus UK Ltd | £9,230,000 † | — | Awarded |
| Lot 2 · Influenza Vaccines for persons aged 18 to 64 years, as recommended by JCVI for 2025/261 award | |||
| Seqirus UK Ltd | £5,670,000 † | — | Awarded |
Contracts
Influenza Vaccines for persons aged 18 to 64 years, as recommended by JCVI for 2025/26 · Seqirus UK Ltd
- Signed
- 9 Jan 2025
- Value
- £5,670,000
- Status
- active
Influenza Vaccine for adults aged 65 years and above as recommended by JCVI for 2025/26 · Seqirus UK Ltd
- Signed
- 9 Jan 2025
- Value
- £9,230,000
- Status
- active
Bid statistics published by the authority
| Lot | Bids | SME | VCSE | Valid bid range |
|---|---|---|---|---|
| 1 · Influenza Vaccine for adults aged 65 years and above as recommended by JCVI for 2025/26 | 1bids · 1 electronic · 1 from abroad | 0 | — | — |
| 2 · Influenza Vaccines for persons aged 18 to 64 years, as recommended by JCVI for 2025/26 | 1bids · 1 electronic · 1 from abroad | 0 | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- Sheriff Court HouseReview body
Bidders & participating suppliers
1 commercial party on the notice- Seqirus UK LimitedAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.